Works matching IS 27705846 AND DT 2025 AND VI 4 AND IP 2

Results: 7
    1
    2
    3

    Pharmacotherapy for Cirrhosis in Japan.

    Published in:
    Portal Hypertension & Cirrhosis, 2025, v. 4, n. 2, p. 111, doi. 10.1002/poh2.70009
    By:
    • Nishikawa, Hiroki;
    • Kim, Soo Ki;
    • Asai, Akira
    Publication type:
    Article
    4

    Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population.

    Published in:
    Portal Hypertension & Cirrhosis, 2025, v. 4, n. 2, p. 91, doi. 10.1002/poh2.70011
    By:
    • Xie, Lindan;
    • Wu, Dandan;
    • Tan, Wenting;
    • Wang, Xianbo;
    • Zheng, Xin;
    • Huang, Yan;
    • Li, Beiling;
    • Meng, Zhongji;
    • Gao, Yanhang;
    • Qian, Zhiping;
    • Liu, Feng;
    • Lu, Xiaobo;
    • Shang, Jia;
    • Shi, Yu;
    • Yan, Huadong;
    • Gu, Wenyi;
    • Zhang, Yan;
    • Hou, Yixin;
    • Zhang, Qun;
    • Xiong, Yan
    Publication type:
    Article
    5

    The Role of Magnesium in Liver Cirrhosis.

    Published in:
    Portal Hypertension & Cirrhosis, 2025, v. 4, n. 2, p. 120, doi. 10.1002/poh2.70007
    By:
    • Zeng, Weiye;
    • Wang, Xudan;
    • Qi, He;
    • Tang, Hongtao;
    • Qi, Xun
    Publication type:
    Article
    6

    Issue Information.

    Published in:
    Portal Hypertension & Cirrhosis, 2025, v. 4, n. 2, p. i, doi. 10.1002/poh2.70012
    Publication type:
    Article
    7